Related Experiment Videos

Rapid detection of the prion protein M129V polymorphism with the LightCycler

Daniel Teupser1, Norman Heino, Wolfgang Wilfert

  • 1Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Liebigstr. 27, 04103 Leipzig, Germany. daniel@teupser.de

Insights

A new fluorescent assay rapidly detects the prion protein M129V gene polymorphism, crucial for Creutzfeldt-Jakob disease (CJD) susceptibility. This reliable method aids in high-throughput genetic screening for CJD risk.

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • The prion protein gene's codon 129 single nucleotide polymorphism (SNP) is vital for Creutzfeldt-Jakob disease (CJD) genetic susceptibility.
  • A recent molecular classification of sporadic CJD utilizes the M129V genotype.

Purpose of the Study:

  • To develop and validate a rapid, fluorescent-based assay for detecting the prion protein M129V polymorphism.
  • To enable high-throughput genotyping for CJD risk assessment.

Main Methods:

  • Development of a fluorescent assay utilizing the LightCycler system.
  • Distinguishing between 129V and 129M alleles based on melting point differences.
  • Confirmation of results using DNA sequencing and evaluation in 400 patient samples.

Main Results:

  • The assay clearly differentiated the 129V (52.1°C) and 129M (60.4°C) alleles.
  • No deviations from expected melting patterns were observed in 400 patient samples.
  • The calculated allele frequency for the M-allele was 0.66.

Conclusions:

  • A rapid, reliable, and high-throughput fluorescent assay for the prion protein M129V polymorphism has been established.
  • This assay facilitates efficient genetic screening related to CJD susceptibility.
  • The method provides accurate genotyping for molecular classification of CJD.

Related Concept Videos